INSIGHTS:
INDUSTRY REPORTS
Our industry reports leverage in-depth research into market dynamics, competitive landscape, technological innovations, cutting-edge applications, and more to develop comprehensive sector analyses. We pride ourselves on delivering unique and sustainable reports that guide our investment and consulting work. Make sure to check out our Health Tech Innovation Atlas' for an even deeper dive into our areas of interest.
_edited_edited.png)
AI Drug Discovery
In early 2020, the first AI-designed drug entered human clinical trials. Less than three years later, the FDA granted its first Orphan Drug Designation to Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis. With continued market adoption and technological advancement, AI is poised to revolutionize drug discovery.
Digital Diagnostics
AI digital diagnostics is a growing field that uses data analytics and machine learning (ML) to develop innovative and non-invasive solutions for diagnosing patients quickly, accurately, and, in many cases, remotely. The main applications of AI in diagnostics are medical imaging analysis, remote diagnostic monitoring (RDM), point-of-care testing, and diagnostic decision support systems (DDS).
Comprehensive
Care Models
Following decades of reproach on the US health system’s persistently flailing return on investment, a new wave of startups has stepped back and reassessed the model driving care delivery. Evolving from a long history of value-based care initiatives—from HMOs, to ACOs, to CMMI’s recent Making Care Primary Model—these companies have forged a new, but unsurprising, space within healthcare: the comprehensive care model.
Gene Therapy
Gene therapy is an innovative and rapidly growing treatment modality, poised to redefine how diseases of all types are treated over the coming decades. With an annual compounded market growth rate greater than 20% through 2030, such paradigm-shifting innovation in gene therapy has attractive market potential.
3D Bioprinting
On a mission to create a human lung using living cells, 3D Systems acquired two up-and-coming 3D bioprinting companies, Allevi and Volumetric, in 2021. Notably, these innovations and transactions are hardly outliers. Within the past five years, there has been marked development in the 3D bioprinting space, with mergers, acquisitions, and fundraising activity in full swing alongside rapid technological advancement.
Healthcare in the Metaverse
[Extended Reality]
As a proposed evolution of the internet, the metaverse could play a major role in the outlook of many industries across the economy. Accordingly, we must look forward with a critical eye at how the technology of tomorrow may reshape healthcare – an industry traditionally defined by its risk aversion and conservative uptake of technology.
Interested in learning more?